1. Association, American Lung. Trends in
COPD (Chronic Bronchitis and Emphysema):Morbidity and Mortality. Epidemiology
and Statistics Unit, Research and Program Services Division. 2011. pp. 1-28.
2. Which Patients
with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Benefit from
Noninvasive Positive-Pressure Ventilation? A Systemic Review of the Literature.
Keenan, SP, et. al. 2003, Annals of Internal Medicine, Vol. 138, pp.
861-870.
3. Chronic
obstructive pulmonary disease. Madison, JM, Irwin, R. 1998, The
Lancet, Vol. 352, pp. 467-473.
4. Smoking Patterns
in African Americans and Whites With Advanced COPD. Chatila WM, Wynkoop
WA, Vance G, Criner GJ. 1, 2004, Chest, Vol. 125, pp. 15-21.
5. Racial
Differences in Quality of Life in Patients with COPD. Han MK,
Curran-Everett D, Dransfield MT, Criner GJ, Zhang L, Murphy JR, Hansel NN,
DeMeo DL, Hanania NA, Regan EA, Make BJ, Martinez FJ, Westney GE, Foreman MG
and Investigators, COPDGene. 5, Nov 2011, Chest, Vol. 140, pp. 1169-76.
Epub 2011 Jun 2.
6. The Health
Consequences of Smoking. A Report of the Surgeon General . Services,
U.S. Department of Health and Human. 2004.
7. Pitts SR, et al.
National Hospital Ambulatory Medical Care Survey:2006 emergency department
summary. Available at:. 2006.
8. St. Peter RF,
Swanljung PT, Cunningham PJ, McGinnis JM. Counseling Patients to Quit
Smoking: Missed Opportunities and the Need to Better Target Physician
Counseling. s.l. : Kansas Health Institute, Center for Studying Health
System Change, National Academy of Sciences, 2002.
9. Review of Adult
Smoking Cessation Interventions Conducted in the Emergency Department and
Application to the Pediatric Emergency Department Setting. Mahabee-Gittens
EM, Gordon JS. 2008, US Respiratory Disease, pp. 125-128.
10. Emergency
department-initiated tobacco control: a randomised controlled trial in an inner
city university hospital. B Neuner, E Weiss-Gerlach, P Miller, P Martus,
D Hesse, C Spies. 4, 2009, BMJ, Vol. 18, pp. 283-293.
11. Diagnosis and
management of stable chronic obstructive pulmonary disease: a clinical practice
guideline from the American College of Physicians. Qaseem A, Snow V,
Shekelle P, et al., fir the Clinical Efficacy Assessment Subcommittee of the
American College of Physicians. 9, 2007, Ann Intern Med, Vol. 147, pp.
633-638.
12. Asthma G.A.P. II
Study:Asthma G.A.P. in America: General Awareness and Perceptions. s.l. :
Asthma and Allergy Foundation of America, 2007.
13. The widening
black/white gap in asthma hospitalizations and mortality. Gupta RS,
Carrion-Carire V, Weiss KB. 2, Feb 2006, J Allergy and Clin Immunology,
Vol. 17, pp. 351-358.
14. Physician and
patient. Barr R.G., Celli B.R., Martinez F.J. et al. 12, Dec 2005,
Am. J. Med, Vol. 118, p. 1415.
15. Abdolrasulnia M,
l Foster J, Shewchuk R, DesLauriers M, Burton BS, WalshJ. Variations in
Primary Care COPD Care.
16. Barriers to
adherence to chronic obstructive pulmonary disease guidelines by primary care
physicians. Salinas GD, Williamson JC, Kalhan R,Thomashow B,
Scheckermann JL, Walsh J, Abdolrasulnia M, Foster JA. March 4, 2011,
International Journal of COPD, Vol. 6, pp. 171-179.
17. Effectiveness of
Continuing Medical Education. Evidence Report/Technology Assessment No. 149
(Prepared by the Johns Hopkins. Marinopoulos SS, Dorman T, Ratanawongsa
N, Wilson LM, Ashar BH, Magaziner JL, Miller RG, Thomas PA, Prokopowicz GP,
Qayyum R, Bass EB. Rockville, MD: Agency for Healthcare Research and
Quality : s.n., Jan;(149) 2007, Evid Rep Techno Assess (Full Rep), pp.
1-69. PMID:177642.
18. Features and
uses of high-fidelity medical simulations that lead to effective learning:a
BEME systematic review. Issenberg SB, McGaghie WC, Petrusa ER, Gordon
DL, Scalese RJ. 1, Jan 2005, Med Teach, Vol. 27, pp. 10-28. PMID: 16147767
[PubMed - indexed for MEDLINE].
19. Factors
Associated with Frequency of Emergency Department Visits for Chronic
Obstructive Pulmonary Disease Exacerbation. Tsai, Chu-Lin, Griswold, SK,
et a. 2007, Society of General Internal Medicine, Vol. 22, pp. 799-804.
20. Trends in COPD
(Chronic Bronchitis and Emphysema):Morbidity and Mortality. s.l. :
American Lung Association, Epidemiology and Statistics Unit, 2011. pp. 1-28.
21. Comparison of Physician-, Biomarker-,and
Symptom-Based Strategies for Adjustment of Inhaled Corticosteroid Therapy in
Adults With Asthma: The BASALT Randomized Controlled Trial. William J. Calhoun, MD; Bill T. Ameredes, PhD; Tonya S. King, PhD;Nikolina
Icitovic, MAS; Eugene R. etal JAMA. 2012;308(10):987-997
22. Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy
Huib A.M. Kerstjens, M.D., Michael Engel, M.D., Ronald Dahl, M.D. etal N Engl J
Med 2012;367:1198-207.
23. Effect of β2-adrenergic receptor polymorphism on response to long acting β2
agonist in asthma (LARGE trial): a genotype-stratified, randomised,
placebo-controlled, crossover trial
Michael E Wechsler, Susan J Kunselman, Vernon M Chinchilli etal Lancet
2009; 374: 1754–64
24. Safe use of long-acting b-agonists: what have we learnt?
Malcolm R Sears Expert Opin. Drug Saf. (2011) 10(5):767-778
25. Step-up Therapy for Children with Uncontrolled Asthma Receiving Inhaled
Corticosteroids
Robert F. Lemanske, Jr., M.D., David T. Mauger, Ph.D., Christine A. Sorkness,
Pharm.D., etal N Engl J Med 2010;362:975-85.